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Abstract
Life sciences has always been an important part of the human space program. The effects of space flight on humans were monitored from the beginning and some research was conducted in the Gemini and Apollo programs. But it was only when a space station, Skylab, was available that we were able to perform in-depth medical experiments to examine the responses of humans to space flight. Since Skylab, flight research programs have been and still are progressing toward our goals of helping astronauts live in space for long periods of time and readapt to Earth's gravity as rapidly as possible, and studying the response of living systems to microgravity.
The Spacelab program provides the opportunity to conduct extensive research on short-term missions to lay the foundation for safe, productive, long duration missions on Space Station Freedom. Researchers around the world are involved in the investigations performed on Spacelab missions. To date, seven Spacelab missions involving life sciences investigations have been flown and five are currently in development. Four of these missions are dedicated to life sciences research. The first of the series, Spacelab Life Sciences 1 (SLS-1), was completed in June, 1991. The remaining missions, SLS-2, SLS-3, and SLS-4 are all currently in different stages of development. SLS-2 will continue the research conducted on SLS-1, SLS-3 will focus on musculoskeletal research, and SLS-4 will focus on neuroscience research.
During the series of Spacelab missions, sophisticated equipment for research and operational use in space has been developed which has allowed more extensive experiments to be conducted. Real-time data acquisition and communication with the crew also allow ground-based investigators to participate in the performance of their investigations, thereby providing enhanced scientific return.
The remaining Spacelab missions promise to build on the knowledge gained from previous missions to provide further understanding of physiologic changes occurring in and resulting from space flight. Investigation results and lessons learned from each of these missions will be used to influence future space shuttle missions and Space Station Freedom.
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The National Aeronautics and Space Administration's (NASA's) life sciences goal is to 
ensure a safe and productive living and working environment for long duration manned 
stays in space. Prior to sending the first man into space, the effects of space flight on 
animals was investigated for several years. Since that time, extensive research, both 
ground-based and on-orbit, has been and will continue to be conducted to characterize 
and understand the human body's responses to a weightless environment.
The effects of space flight on humans were monitored during Project Mercury and 
limited life sciences research was conducted in the Gemini and Apollo programs. When 
the Skylab space station was available, in-depth, long-duration medical experiments were 
performed. These experiments led to the general conclusions that when astronauts return 
to Earth, they are said to be affected by "deconditioning" and must readapt. The 
physiologic changes that occur during space flight are generally associated with 
adaptation of the body to microgravity. The major responses are changes resulting from 
reduction of the hydrostatic gradient. This causes fluid to be redistributed toward the 
head resulting in a loss of body fluid and corresponding changes in the cardiovascular 
system. Another response, a loss of muscle and bone mass, is thought to be caused by 
the decrease in gravitational forces on the musculoskeletal system. In addition, reduced 
input to gravity-sensitive sensory receptors result in neurosensory changes. Questions 
still to be answered include: What are the mechanisms by which these changes occur? 
Do the changes intensify with time or cease after a certain period? What types of 
countermeasures would be most effective in reducing any consequences? Are there any 
long-term consequences due to these changes following return to 1 gravity?
Today, much of NASA's life sciences research is conducted through the Spacelab 
Program. The Spacelab research facility was built by the European Space Agency. The 
facility is located in the shuttle's cargo bay during Space Shuttle/Spacelab missions. It 
provides an shirt-sleeve atmosphere for the astronauts to perform experiments. 
Instruments and facilities flown inside the Spacelab are designed for use on more than 
one mission. Operationally, real-time data acquisition and communication with the crew 
is possible during flight, and early access to the crew and experiment samples is possible 
upon landing.
NASA's life sciences involvement in the Spacelab Program currently includes seven 
Spacelab missions that have flown and five that are scheduled for flight within this 
decade. The extent of participation has varied, from only a few investigations on a 
mission to a series of missions fully dedicated to life sciences research. Whatever the
5-27
extent of participation, each mission builds on the next, in the areas of life sciences 
knowledge, technology, and operations.
The first series of Spacelab missions was Spacelab (SL) 1,2, and 3. SL-1 was flown in 
November 1983. This was the first test of the facility and several disciplines were 
studied. Life sciences investigations included vestibular studies to provide information 
about the causes of space motion sickness and metabolic studies to analyze changes in 
red and white blood cell count. The SL-2 mission was flown in July 1985. Only limited 
life sciences research was conducted in flight. A vitamin D metabolite and bone 
demineralization study was conducted. Prior to SL-2, SL-3 flew in April 1985. On this 
mission, two life sciences hardware verification tests were performed. One test was for 
the Research Animal Holding Facility (RAHF). Two RAHFs were tested, one held two 
squirrel monkeys and the other held 24 rodents. Functional testing of the RAHFs was a 
necessary step in making it possible to perform in-flight experiments using animals, so 
that animal models for the effects of space flight on humans can be developed. The 
RAHFs maintain the animals in a laboratory-like environment. Although the animals on 
SL-3 were specific-pathogen-free, the RAHFs are designed to prevent cross 
contamination between astronauts and animals. Release of particulate matter from the 
RAHFs was detected during the SL-3 flight and a redesign of the facilities was required 
before they could be flown again. The other hardware verification test on SL-3 was for 
the Urine Monitoring System (UMS). This system, connected to the shuttle's Waste 
Collection System, can collect urine samples and measure urine volumes. Urine samples 
provide important information about changes in human body fluids during 
weightlessness. Air flow problems, discovered during testing of the UMS, were 
corrected prior to its use on future missions.
The next mission to fly was an international mission involving NASA and Germany's 
Space Agency, Deutsche Agentur fur Raumfahrtangelegenheiten (DARA). Deutsche 1 
(D-l) flew in 1985. Studies in the same areas of research as the SL series continued on 
this mission. Several vestibular, metabolic, and cardiovascular studies were performed, 
which included body impedance and venous pressure measurements, and cognitive 
behavior studies. A similar US/German Spacelab mission, D-2, is being planned with the 
DARA.
Another Spacelab series with life sciences investigations, the International Microgravity 
Laboratory (IML) series, is a joint effort between NASA and the European Space 
Agency. It consists of the IML-1 and IML-2 missions. IML-1 was launched in January
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1992 with the life sciences focus on vestibular research. A special rotating chair was 
developed for the performance of a set of in depth vestibular investigations. IML-2 is 
scheduled for launch in June 1994 with an investigation studying the effects of Lower 
Body Negative Pressure as a countermeasure for cardiovascular deconditioning.
The last Spacelab mission flown involving life sciences was Spacelab Japan (SL-J), 
flown in September 1992. The Fluid Therapy System (FTS) being developed for Space 
Station Freedom was successfully tested on this mission. Intravenous solutions were 
made during flight and delivered by an intravenous pump to a mannequin arm. Part of 
this system, the intravenous pump, had been tested on the Spacelab Life Sciences 1 
(SLS-1) mission. A problem with the pump that was encountered on SLS-1 was solved 
prior to the complete test of the system conducted on SL-J. Other investigations included 
a frog embryology study, a bone formation study using chicken embryos, and a passive 
radiation study.
The first dedicated life sciences Spacelab mission, SLS-1, was flown in June 1991. It 
was the first in the series of four Spacelab missions dedicated to life sciences research. 
Several space life sciences "firsts" were achieved on this mission. For the first time, a 
catheter used for measuring central venous pressure was worn by a crew member during 
launch and the first few hours of the mission. This permitted the first direct measurement 
of central venous pressure in space. Central venous pressure would be expected to show 
the effect of microgravity on the distribution of body fluids. Another first in 
cardiovascular research was measurement of the baroreflex, the sensor that monitors 
blood pressure in the neck and regulates it speeding or slowing the heart. The 
measurements confirmed the theory that the baroreflex is less efficient in space and on 
recovery than it normally is. A first for metabolic research includes the collection of 
blood samples within hours of entry into weightlessness. These measurements revealed 
that the body begins to adapt sooner than previously expected. SLS-1 was also the first 
time physiologic tracers were administered on-orbit.
Previously tested and modified hardware also flew on SLS-1. The UMS, which was 
tested on SL-3, was flown and used successfully on SLS-1. Urine samples were obtained 
and their volumes measured. The samples were stored in a freezer until their return for 
postflight analysis. One rodent RAHF, redesigned after SL-3, was flown on SLS-1. No 
problems with the facilities were noted this time. Rodent tissue samples were obtained 
before and after flight for studies of blood cell formation, muscle metabolism, bone 
metabolism, and gravity receptor structure.
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A General Purpose Workstation (GPWS) flown on this mission was used in an 
experiment involving the development of jellyfish in microgravity, a neuroscience 
research investigation. The workstation provided a fume hood environment for use of 
chemicals needed for the experiment. A rodent was also transferred from the RAHF to 
the GPWS to observe the behavior of the animal and to test the capability of handling 
animals in the workstation.
Operations at landing, as well as in-flight capabilities, have advanced since the beginning 
of the Spacelab Program, A Crew Transport Vehicle (CTV) was used for the first time at 
the landing of SLS-1. This vehicle allows postflight data collection on returning crew to 
begin sooner than ever before. Returning astronauts enter the CTV directly from the 
orbiter and can begin postflight physicals and data collection while on the way to the 
postflight clinic.
The second life sciences dedicated Spacelab mission, SLS-2, is scheduled for launch this 
year. Research started on SLS-1 will continue on SLS-2. Most of the investigations 
from SLS-1 will be repeated on SLS-2 to increase the number of subjects in the human 
investigations. Rodents will also be flown on SLS-2, and for the first time tissue samples 
will be obtained from rodents during flight and returned to Earth for analysis.
The last two life sciences dedicated Spacelab missions, SLS-3 and SLS-4, are both 
currently in their development stages. SLS-3 will focus on musculoskeletal research and 
SLS-4 will focus on neuroscience research, two areas that are of major interest to NASA. 
Both missions will 'be flying the Rhesus Research Facility (RRF). The RRF is being built 
by the Preach Space Agency, Centre National d'Etudes Spatiales, and NASA. It will be 
capable of housing two adult rhesus monkeys. SLS-3 is scheduled for launch in January 
1996 and SLS-4 is scheduled for launch in 1998. '
Scientific knowledge gained from each mission is used to design new investigations. 
Data collected from the more recent missions is being analyzed. By the start of Space 
Station Freedom activities, answers to many of NASA's questions will have been found. 
Technological advances include all the equipment that has flown successfully, including 
the UMS and FTS, and facilities such as the RAHFs and the future RRF that is currently 
being designed. Operational advances have also been made. The capability to allow 
investigators to acquire data from their experiment real-time and communicate with the 
crew during the performance of the investigation is now available unlike the previous 
Sky lab Program. Also, early, access to experiment samples is possible upon landing.
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Lastly, with the use of the CTV, access to the crew for postflight data collection is 
possible within an hour of landing. -
Each of NASA's manned space flight programs has provided more insight into the 
physiologic changes associated with space flight, starting with the data gathered from 
medical monitoring during Project Mercury, and advancing to the sophisticated 
biomedical investigations currently conducted on Space Shuttle/Spacelab missions. Each 
new discovery continues to influence space shuttle missions, and will continue to 
influence Space Station Freedom and future space exploration.
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